ArticleCNS neuroscience & therapeutics2024

Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III.

Mengnan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.